Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 11/20 | 0.47 |
| ▸ | PPARA | Q07869 | 4/20 | 0.47 |
| ▸ | PPARD | Q03181 | 3/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5422007 | 1.00 | PPARG (0.49) | PPARGFFAR1PPARAPPARDFFAR4 | |
| SCHEMBL5414627 | 0.90 | PPARG (0.51) | PPARGPPARAPPARDLTB4RRXRA | |
| SCHEMBL5414621 | 0.90 | PPARG (0.51) | PPARGPPARAPPARDLTB4RRXRA | |
| SCHEMBL5427796 | 0.90 | PPARG (0.51) | PPARGPPARAPPARDLTB4RRXRA | |
| SCHEMBL5419520 | 0.87 | FFAR1 (0.46) | PPARGFFAR1PPARAPPARDFFAR4 | |
| SCHEMBL5423804 | 0.87 | PPARG (0.51) | PPARGFFAR1PPARAPPARDRXRA | |
| SCHEMBL5419513 | 0.87 | FFAR1 (0.46) | PPARGFFAR1PPARAPPARDFFAR4 | |
| SCHEMBL5423799 | 0.87 | PPARG (0.51) | PPARGFFAR1PPARAPPARDRXRA | |
| SCHEMBL5422020 | 0.86 | PPARG (0.49) | PPARGPPARARXRARXRB | |
| SCHEMBL5422015 | 0.86 | PPARG (0.49) | PPARGPPARARXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070167490-A1 | Imino ether derivative compounds and drugs containing the compounds as the active ingredient | ONO PHARMACEUTICAL CO LTD | 2007-07-19 | — | — | US | disclosed |
| EP-1602642-A1 | IMINO ETHER DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167490-A1 | Imino ether derivative compounds and drugs containing the compounds as the active ingredient | INSR, NR1H2, NR1H3 | PPARG 18/4885FFAR1 90/4885PPARA 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.